To evaluate the effect of zafirlukast on capsular contracture around silicone implants by measuring the pressure within the implant, using a rat experimental model. METHODS: Forty adult female Wistar rats were used. Each one received two silicone implants, one with smooth-surface and the other with textured-surface. They were randomly divided into four groups (n=10). The rats of control group I were sacrificed after the implants. The remaining animals were subjected to a daily regimen of intra-peritoneal injection for a period of 90 days and they were distributed as follows: control group II received 0.9% physiological saline solution; experimental group I received zafirlukast 1.25 mg/kg; and experimental group II received zafirlukast 5 mg/kg. The measurement of intra-implant pressure of control group I was determined on the surgery day and in other groups on the ninetieth day, after being sacrificed. RESULTS: In the evaluation of textured implants there was an increase of internal pressure in the control group II, and there was no increase in the experimental groups. Compared to the controls there were not significant differences in smooth implants. CONCLUSION: Zafirlukast reduced the risk of developing capsular contracture around silicone implants with textured surface. Key words: Breast Implants. Implant Capsular Contracture. Leukotriene Antagonists. Rats. RESUMO OBJETIVO: Avaliar o efeito do zafirlukast na contratura capsular ao redor de implantes de silicone, através da aferição da pressão intra-implante, utilizando-se um modelo experimental de ratos. MÉTODOS: Quarenta ratos fêmeas Wistar foram utilizados. Cada um recebeu dois implantes de silicone, sendo um com superfície lisa e outro texturizada. Foram divididos aleatoriamente em quatro grupos (n=10). Os ratos do grupo controle I foram sacrificados após o implante. O restante dos animais foi submetido a um regime diário de injeção intraperitoneal por um período de 90 dias e foram distribuídos: grupo controle II recebeu solução salina fisiológica 0,9%, grupo experimental I recebeu zafirlukast 1,25 mg/kg, e grupo experimental II recebeu zafirlukast 5 mg/kg. O grupo controle II recebeu solução salina; grupo experimental I, 1,25 mg/kg/dia de zafirlukast; grupo experimental II, 5mg/kg/dia de zafirlukast. A aferição da pressão intra-implante do grupo controle I foi averiguada no dia do ato operatório, e nos outros grupos no nonagésimo dia, após serem sacrificados. RESULTADOS: Na avaliação dos implantes texturizados houve aumento da pressão interna no grupo controle II e, não se observou aumento nos grupos experimentais. Na comparação com os controles não foram observadas diferenças significativas nos implantes lisos. CONCLUSÃO: O Zafirlukast reduziu o risco de desenvolver contratura capsular em torno de implantes de silicone com superfície texturizada. Descritores: Implantes de Mama. Contratura Capsular em Implantes. Antagonistas de Leucotrienos. Ratos.
Introduction
The search for breast implant surgery is increasing each year. According to the American Society for Aesthetic Plastic Surgery (ASAPS) 1 , in 2009, over 289.000 procedures were conducted exclusively for breast augmentation. In Brazil, according to the Brazilian Society of Plastic Surgery (SBCP) 2 , this number is over 150.000.
In this type of surgery, the capsular contracture is the main complication 3, 4 observed in up to 50% 4, 5 of patients in two years following the surgery [3] [4] [5] [6] [7] . The fibrous tissue formed around the prosthesis promotes its compression and can cause esthetic involvement (distortion, asymmetry and hardening of the breast) and painful symptoms [4] [5] [6] [7] [8] [9] , making it sometimes frustrating for both patients and surgeons 5, 6 .
The standard treatment is capsulectomy with implant replacement, which would require additional surgery, with all its risks and inherent burdens 3, [6] [7] [8] [9] [10] . The search for prevention and less morbid/invasive treatment for this phenomenon has been the subject of several studies; however, so far, no study has clearly demonstrated their effectiveness [3] [4] [5] [6] [7] [8] [9] [10] [11] .
Although the actual cause of capsular contracture is still unknown, most authors rely on the hypothesis of a multifactorial process [3] [4] [5] [7] [8] [9] that has inflammation as a common denominator 3, 7, 8 .
Currently, pharmacological inhibition of this inflammation around implants is the main focus of investigation 7, 8 , in the search for prevention and successful treatment of this problem 3, 7, 8 .
It deserves mention a pioneering study conducted by
Schlesinger et al.
12
, which showed a significant improvement in the degree of capsular contracture with the use of zafirlukast (Accolate ® , AstraZeneca), a leukotriene antagonist, for a period of 1 to 3 months, to the extent that, in cases of some women for whom surgical procedures had already been indicated, this proved unnecessary. As a consequence, some authors have attempted to clarify the issue of the mechanisms involved with this drug in the prevention and treatment of capsular contracture 5, 8, [10] [11] [12] [13] [14] [15] [16] [17] [18] . Accordingly, new investigations are important to confirm the beneficial effect of this drug.
The purpose of this experimental study is to evaluate the effect of zafirlukast on capsular contracture around silicone implants by measuring the pressure within the implant, using a rat experimental model.
Methods
The experimental protocol was approved by the 
Experimental groups and surgical procedure
On surgeries, a total of 80 mini silicone implants filled with silicone gel, round-based, 2.2 cm in diameter, volume of two ml and with the same internal pressure were used. Forty mini-implants had textured-surfaces and 40 smooth-surfaces. All 
Measuring the internal pressure of mini-implants
To measure the internal pressure of each implant was performed the pressure measurement generated by the influx of distilled water into the implant; after the opening of the paths that connected the implant to the gauge it was made the reading of this reflux pressure, which inferred the compliance of the capsule (Figure 2 ). For this, it was used a pressure transducer, which The pressure transducer was connected to the gaugereader. A silicone hose was connected to another output. This hose was connected to a three-way system. In one of the ways it was connected a syringe of 1 ml; and in the other one, a nº 19 scalp.
The whole system was filled with distilled water; the transducer and the silicone hose were filled previously and connected to the system, taking care not to let any air bubbles. This system remained untouched (without disconnecting) until the end of the measurements.
The scalp, which was changed at every measurement, was connected to the system and filled with distilled water through the syringe connected to the other way. After the system was fully filled, the ways from the scalp to the gauge were opened, and the initial value of zero was verified (based on atmospheric pressure).
The syringe was then filled with 0.5 ml of distilled water and reconnected to the system. After removal of hair over the implant area, they were positioned at the same level of the system and the "scalp" was introduced into the animal (always the same length of the needle was inserted into the animal). Great care was taken that all connections were at the same level of "zero" calibrated, including the needle inserted into the rat, which had 90 degrees with the syringe in all axes.
Since the gel is very viscous, it did not flow into the system; therefore, a controlled amount of this fluid (0.3 ml) was injected into the implant through the syringe. After this procedure, the ways of the reader and of the scalp were open, so that according to the internal pressure of the mini-implants there was a variable reflux of water into the transducer, which transformed this mechanical signal into electrical signals read by the reader as a Pascal pressure measurement.
Statistical analysis
In the descriptive analysis, data were summarized as 
Results
The final sample analyzed consisted of 33 rats, carrying 33 smooth implants and 31 textured ones. One animal in CI group showed extrusion of two implants and two animals presented implants attached to each other; therefore, they were excluded (remaining 7 rats, 7 smooth, and 7 textured). In group EI one rat was sacrificed due to eye loss caused by local infection; a rat with implants adhered to one another and a loss by measurement error (remaining 7 rats, 7 smooth, and 7 textured). In EII group one rat died of peritonitis because of a probable accident puncture;
and two rats with loss of textured implants after necrosis of the overlying skin (remaining 9 rats, 9 smooth, and 7 textured).
Internal pressure of mini-implants
The value distribution of internal pressures of miniimplants, after the infusion of 0.3 ml of distilled water, in the four groups, is shown in form of box-plot in Figure 3 . groups (EI and EII) no difference was found, which indicates that these groups (EI and EII) showed no capsular contracture. In groups with smooth implants capsular contracture was not found either in the group that received only saline solution or in groups that received zafirlukast ( Table 1) .
The comparative analysis between implant types (textured and smooth) for all groups showed no differences ( Table   2) . 
Discussion
Since the first reports on capsular contracture in the literature, many studies have been conducted in an attempt to prevent its development, using different drugs (such as antibiotics,
anti-neoplastic agents and steroids) administered locally or systemically, but with disappointing results [3] [4] [5] [6] 8, 10, 11 .
It deserves attention the possibility of an oral drug for the treatment of a complication that has serious physical, Recent research has shown that its use in animals 10, 13, 14 and clinical trials 8, 12, [15] [16] [17] In this study, the option for silicone prostheses and not saline ones was due to the greater incidence of capsular contracture found in the use of the former 9 ; the observation time (three months) was based on other studies with rats, which showed that most of the capsular contractures occurred during this period 21 .
As for the method of measuring the complacency of the capsule, it was chosen the method of infusion liquid which had been described by other authors [21] [22] [23] . The use of pressure measurement system was necessary because it seems to be the most objective method to assess capsular contracture. Baker's classification and applanation tonometry did not seem very appropriate to investigate contractures in rats.
The use of implants with textured and smooth surfaces was due to the fact that they behave differently regarding the occurrence of capsular contracture 6, 7 ; however, this matter is not yet consensus in the scientific literature 7 . Therefore, it was opted for the allocation of two types of prostheses in the same rat, so that different responses to the use of zafirlukast could be verified.
The effect of zafirlukast in reducing capsular contracture on textured implants observed in this experiment is consistent with findings from previous studies 10, 13, 14 , which showed that the application of leukotriene antagonist reduced the number of vessels, capsular thickness, collagen density, number of mast cells, eosinophils and myofibroblasts around the prosthesis compared with control. However, the issue of smooth prostheses lacks further responses.
Besides the zafirlukast reducing the formation of capsule around implants (demonstrated in previous studies 10, 13, 14 , the decrease of the contraction had not been demonstrated and by measuring the internal pressures of mini-implants, the present study comes to fill this gap.
Conclusion
Zafirlukast reduced the risk of developing capsular contracture around silicone implants with textured surface in this rat model. 
